Literature DB >> 33719938

Comparison of the protective effect of cytosolic and mitochondrial Peroxiredoxin 5 against glutamate-induced neuronal cell death.

Mi Hye Kim1,2, Da Yeon Kim3, Hong Jun Lee4,5, Young-Ho Park6, Jae-Won Huh7, Dong-Seok Lee1,2.   

Abstract

Objectives: Although glutamate is an essential factor in the neuronal system, excess glutamate can produce excitotoxicity. We previously reported that Peroxiredoxin 5 (Prx5) protects neuronal cells from glutamate toxicity via its antioxidant effects. However, it is unclear whether cytosolic or mitochondrial Prx5 provides greater neuroprotection. Here, we investigated differences in the neuroprotective effects of cytosolic and mitochondrial Prx5.
Methods: We analyzed patterns of cytosolic and mitochondrial H2O2 generation in glutamate toxicity using HyPer protein. And then, we confirmed the change of intracellular ROS level and apoptosis with respective methods. The mitochondrial dynamics was assessed with confocal microscope imaging and western blotting.
Results: We found that the level of mitochondrial H2O2 greatly increased compared to cytosolic H2O2 and it affected cytosolic H2O2 generation after glutamate treatment. In addition, we confirmed that mitochondrial Prx5 provides more effective neuroprotection than cytosolic Prx5.Discussion: Overall, our study reveals the mechanisms of cytosolic and mitochondrial ROS in glutamate toxicity. Our findings suggest that mitochondrial ROS and Prx5 are attractive therapeutic targets and that controlling these factors be useful for the prevention of neurodegenerative diseases.

Entities:  

Keywords:  Cytosolic ROS; HT22; Hydrogen peroxide; Hyper; Peroxiredoxin 5; apoptosis; glutamate; mitochondrial ROS

Mesh:

Substances:

Year:  2021        PMID: 33719938      PMCID: PMC7971343          DOI: 10.1080/13510002.2021.1901028

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  36 in total

Review 1.  The role of excitotoxicity in neurodegenerative disease: implications for therapy.

Authors:  A Doble
Journal:  Pharmacol Ther       Date:  1999-03       Impact factor: 12.310

Review 2.  Peroxiredoxins as biomarkers of oxidative stress.

Authors:  Rebecca A Poynton; Mark B Hampton
Journal:  Biochim Biophys Acta       Date:  2013-08-09

Review 3.  The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.

Authors:  Sybil Obuobi; Sanzhar Karatayev; Christina Li Lin Chai; Pui Lai Rachel Ee; Peter Mátyus
Journal:  J Enzyme Inhib Med Chem       Date:  2016-07-07       Impact factor: 5.051

Review 4.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Authors:  Simran S Sabharwal; Paul T Schumacker
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

5.  Peroxiredoxin 5 Inhibits Glutamate-Induced Neuronal Cell Death through the Regulation of Calcineurin-Dependent Mitochondrial Dynamics in HT22 Cells.

Authors:  Mi Hye Kim; Hong Jun Lee; Sang-Rae Lee; Hyun-Shik Lee; Jae-Won Huh; Yong Chul Bae; Dong-Seok Lee
Journal:  Mol Cell Biol       Date:  2019-09-27       Impact factor: 4.272

Review 6.  Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis.

Authors:  Kalavathi Dasuri; Le Zhang; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2012-09-19       Impact factor: 7.376

Review 7.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases.

Authors:  Xiao-xia Dong; Yan Wang; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

Review 8.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

9.  Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells.

Authors:  Junghyung Park; Hoonsung Choi; Ju-Sik Min; Sun-Ji Park; Jung-Hak Kim; Hyo-Jin Park; Bokyung Kim; Jung-Il Chae; Mijung Yim; Dong-Seok Lee
Journal:  J Neurochem       Date:  2013-07-29       Impact factor: 5.372

Review 10.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Xinglong Wang; Wenzhang Wang; Li Li; George Perry; Hyoung-gon Lee; Xiongwei Zhu
Journal:  Biochim Biophys Acta       Date:  2013-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.